McKesson (MCK) Reaches $1,105 and Sets a New All-Time High

As seen on the 24/7 Wall St. homepage on November 16, 2026.

MCK McKesson
52-week high
$1105.15
+0.21% vs prior 52-week high · Nov 13, 2026
$1.1k$914$693

McKesson set another record high at $1,105.15, topping the mark it just made on Nov. 13. Rival Cardinal Health rose 0.97% while customer CVS Health slipped 0.82%.

Before the move last 24 hours
  1. Jim Cramer
    We just get me into McKesson. Please. Can I just have some Amgen?
Related stocks today
  • CAHCardinal HealthCompetitor+1.0%
    Jun 30, 2026 · SEC 10-K
  • CVSCVS HealthCustomer-0.8%
    Mar 31, 2026 · SEC 10-K
  • TAKTakeda PharmaceuticalSupplier+0.8%
    Jun 17, 6:06 AM ET · SEC 10-K

Moves: Nov 16, 2026 · Alpha Vantage daily close

5 more related stocks

Continue ReadingShow less

McKesson closed at $1,105.15 on November 16, overtaking the record high it had set just three days earlier on November 13. That back-to-back record is notable because it suggests buying pressure has not faded after the initial breakout, which is often when momentum tends to stall.

The stock spent much of the year trading well below the $900 level before accelerating sharply in recent weeks, and the pace of those gains has steepened.

Sponsored

The day's gain of 0.21% was modest, with competitor Cardinal Health rising 0.97% and customer CVS Health slipping 0.82%. Softening at a major pharmacy customer is worth monitoring, since McKesson's pharmaceutical distribution business is tied to the health of retail pharmacy chains.

CNBC's Jim Cramer publicly asked to be added to McKesson on November 16, saying 'We just get me into McKesson. Please.' That kind of on-air endorsement can draw short-term retail attention to a stock, though it arrived on the same day as the new high rather than ahead of it.

Mentioned: MCK, CAH, CVS